NPC Provides Comments to CMS on the Notice of Benefit and Payment Parameters (NBPP) for Calendar Year 2026 Read more about NPC Provides Comments to CMS on the Notice of Benefit and Payment Parameters (NBPP) for Calendar Year 2026
NPC Submits Comments to CMS on Proposed Rule on CY 2025 Payment Policies and More Read more about NPC Submits Comments to CMS on Proposed Rule on CY 2025 Payment Policies and More
NPC Submits Comments Regarding the Medicare Hospital Outpatient Prospective Payment System Read more about NPC Submits Comments Regarding the Medicare Hospital Outpatient Prospective Payment System
NPC responds to CMS's Information Collection Request on the Negotiation Data Elements and Drug Price Negotiation Process for the Initial Price Applicability Year 2027 Read more about NPC responds to CMS's Information Collection Request on the Negotiation Data Elements and Drug Price Negotiation Process for the Initial Price Applicability Year 2027
NPC Submits Comments to CMS on Draft Guidance for the Medicare Drug Price Negotiation Program for 2027 Read more about NPC Submits Comments to CMS on Draft Guidance for the Medicare Drug Price Negotiation Program for 2027
New Primer Highlights Unanswered Questions and Unintended Consequences of State Prescription Drug Affordability Boards Read more about New Primer Highlights Unanswered Questions and Unintended Consequences of State Prescription Drug Affordability Boards
Talking Points on ICER and NEWDIGS Gene Therapy White Paper (April 2024) Read more about Talking Points on ICER and NEWDIGS Gene Therapy White Paper (April 2024)
Acknowledging the Challenges in Gene Therapy: Perspectives on ICER's White Paper Read more about Acknowledging the Challenges in Gene Therapy: Perspectives on ICER's White Paper
It’s time to stop talking past each other on drug pricing Read more about It’s time to stop talking past each other on drug pricing